The University Health Network (UHN) Genome Diagnostics laboratory was one of two initially funded provincial laboratories, providing a unique opportunity to evaluate the detection rate of tumor BRCA1/2 variants in a large, population‐based, tumor testing program. Here, BRCA1 is linked to neoplasm.